Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02208466 · ClinicalTrials.gov registry record · Phase 2
Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients
A Phase 2 study, sponsored by Spaulding Rehabilitation Hospital.
- Completed
- Registry status
- Phase 2
- Development phase
- 44
- Enrollment target
NCT02208466: Completed Phase 2 study, sponsored by Spaulding Rehabilitation Hospital.
NCT02208466 is a Phase 2 study that has completed, run by Spaulding Rehabilitation Hospital. The registered enrollment target is 44 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02208466, a Phase 2 study, has completed, sponsored by Spaulding Rehabilitation Hospital.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 44 participants
- Enrollment target
Study Summary
In this study investigator's aim to assess the effect of a type of non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) in conjunction with fluoxetine on motor recovery after stroke.
Primary Outcome
Jebsen Taylor Hand Function Test: measures hand function in real-life activities, by evaluating the time required to perform 7 different tasks. We used the non-constrained hand for the assessments. The sum of the different tasks was used for the analysis. Calculation details: value at 9 months minus value at baseline, change in seconds (adjusted mean difference).
Interventions
- DRUG Fluoxetine
- DEVICE Active Repetitive Transcranial Magnetic Stimulation (rTMS)
- DEVICE Sham repetitive transcranial magnetic stimulation (rTMS)
- DRUG Placebo Fluoxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2014-09 |
| Est. Completion | 2019-06-25 |
| Phase | Phase 2 |
What the finished NCT02208466 record still lists
NCT02208466 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 4 interventions - of which Fluoxetine is the first listed.
NCT02208466 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02208466 about?
NCT02208466 is a clinical study titled "Effects rTMS Combined With Fluoxetine on Motor Recovery in Stroke Patients". In this study investigator's aim to assess the effect of a type of non-invasive brain stimulation technique called repetitive transcranial magnetic stimulation (rTMS) in conjunction with fluoxetine on motor recovery after stroke.
What is the current status of trial NCT02208466?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 44 participants. The study started on 2014-09. Estimated completion is 2019-06-25.
What interventions are being tested in trial NCT02208466?
The interventions under investigation include: Fluoxetine (DRUG), Active Repetitive Transcranial Magnetic Stimulation (rTMS) (DEVICE), Sham repetitive transcranial magnetic stimulation (rTMS) (DEVICE), Placebo Fluoxetine (DRUG).
Who is sponsoring clinical trial NCT02208466?
This trial is sponsored by Spaulding Rehabilitation Hospital, which has 101 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02208466's enrollment target sits among peer trials
44 1322nd of 2000 higher than 669 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia